Quarterly reports
Health Catalyst's second quarter of fiscal 2026 showed a business still shrinking at the top line while cost cuts held the bottom line roughly steady. Total revenue fell to $70.49 million for the quarter ended June 30, 2026, down 12.7% from $80.72 million in the prior-year quarter.
Health Catalyst reported first quarter fiscal 2026 revenue of $70.8 million, down 10.9% from $79.4 million in the prior-year quarter. Both segments shrank. Technology revenue was 70% of the total and professional services was 30%, a mix shift toward technology from 65% and 35% a year earlier.
Health Catalyst closed fiscal 2025 with fourth-quarter revenue of $74.68 million, down 6.2% from the prior-year quarter. Full-year revenue reached $311.14 million, up 1.5%. The bottom line deteriorated sharply. The fourth-quarter net loss was $91.02 million, and the full-year net loss was $177.97 million.
Health Catalyst reported third-quarter 2025 total revenue of $76.3 million, essentially flat versus the prior-year quarter. Gross margin was 52.6%, up 5.1 percentage points from the prior-year quarter. The bottom line deteriorated. Net loss was $22.2 million, wider than the prior-year quarter.
Health Catalyst reported second quarter revenue of $80.7 million, up 6.3% from the prior-year quarter, and first half revenue of $160.1 million, up 6.3% from the prior-year period. The GAAP bottom line moved sharply lower.
Health Catalyst reported first quarter 2025 total revenue of $79.4 million, up 6.3% from $74.7 million in the prior-year quarter. Growth came from new clients, acquired relationships, and expansion from existing clients. The operating loss narrowed to $20.2 million from $22.8 million.
Health Catalyst closed fiscal 2024 with fourth-quarter revenue of $79.6 million, up 6% from the prior-year quarter. Full-year revenue reached $306.6 million, up 4%. The company continued to shrink its losses. Fourth-quarter operating loss was $17.5 million, narrowed from $32.8 million a year earlier.
Health Catalyst reported third quarter 2024 revenue of $76.4 million, up 3.5% from $73.8 million in the prior-year quarter. Year-to-date revenue was $227.0 million, up 2.8% from $220.9 million. Technology made up 64% of quarterly revenue and professional services 36%.
Health Catalyst reported total revenue of $75.9 million for the second quarter of fiscal 2024, up 3.7% from the prior-year quarter. Year-to-date revenue was $150.6 million, up 2.4%. The operating loss narrowed to $15.8 million for the quarter and to $38.6 million for the first six months.
Health Catalyst reported $74.7 million of total revenue for the first quarter of 2024, up 1.2% from $73.9 million in the prior-year quarter. Growth was thin and came mainly from new clients and expansion at existing ones, with the heaviest contribution from Tech-enabled Managed Services.
Health Catalyst closed fiscal 2023 with $75.1 million in fourth-quarter revenue, up 8.6% year over year. Full-year revenue reached $295.9 million, up 7.1%. The company stayed unprofitable on a GAAP basis. Fourth-quarter operating loss was $32.8 million, a 10.8% improvement.
Health Catalyst reported preliminary third quarter 2023 results on October 27, 2023. Total revenue was $73.8 million, up 7.9% from the prior-year quarter. Year-to-date revenue was $220.9 million, up 6.7%. The company reported a net loss of $22.0 million, narrowed 51.8% from the prior-year quarter.
Health Catalyst reported second quarter 2023 revenue of $73.2 million, up 3.7% from the prior-year quarter. First half revenue reached $147.1 million, up 6.0% year over year.
Health Catalyst reported total revenue of $73.9 million for the first quarter of fiscal 2023, up 8.5% from $68.1 million in the prior-year quarter. The top line grew, but profitability moved the other way.
Health Catalyst ended fiscal 2022 with fourth-quarter revenue of $69.16 million, up 6.9% from the prior-year quarter. Full-year revenue reached $276.24 million, up 14.2%. The top line grew even as the health system end market remained under pressure.
Health Catalyst reported total revenue of $68.4 million for the third quarter of fiscal 2022, up 10.7% from $61.7 million in the prior-year quarter. For the nine months ended September 30, 2022, revenue reached $207.1 million, up 16.9% from $177.2 million a year earlier.
Health Catalyst reported total revenue of $70.6 million for the second quarter of fiscal 2022, up 18% from $59.6 million in the prior-year quarter. Technology revenue grew faster than professional services revenue, shifting the mix to 64% technology and 36% professional services, against 60% and 40% a year earlier.
Health Catalyst reported total revenue of $68.1 million for the first quarter of fiscal 2022, up 21.9% from $55.8 million in the prior-year quarter.
Health Catalyst closed fiscal 2021 with fourth-quarter total revenue of $64.7 million, up 21.5% from the prior-year quarter. Full-year revenue reached $241.9 million, up 28.1% from 2020. The top line grew, but the company remained deeply unprofitable.
Health Catalyst reported total revenue of $61.7 million for the third quarter of fiscal 2021, up 30.8% from $47.2 million in the prior-year quarter. Technology accounted for 62% of the total and professional services 38%, a mix that shifted toward technology from 59% and 41% a year earlier.
Health Catalyst reported second quarter 2021 total revenue of $59.6 million, up 37.8% from the prior-year quarter. Year-to-date revenue reached $115.5 million, up 30.7% from the prior-year period. The company also reported a net loss of $35.8 million, and the loss widened from the prior-year quarter.
Health Catalyst closed its fiscal 2021 first quarter with total revenue of $55.8 million, up 23.8% from the prior-year quarter. The top line benefited from new customers, acquired technology customers, and contractual annual escalators. The company still operates at a loss.
Summaries, guidance, risks and KPIs are generated from the company's SEC filings (10-Q / 10-K and the 8-K earnings release) and checked against the reported XBRL figures. They can contain errors; the filings are authoritative.